Teleflex (NYSE:TFX) announced today that it entered into a new agreement with FundamentalVR over integration for medical simulation. Wayne, Pennsylvania-based Teleflex’s agreement with FunamentalVR, a leader in virtual reality (VR) integration for medical simulation, will provide Teleflex with a VR training platform to accelerate the effective use of its UroLift 2 system. UroLift 2, a […]
Men's Health
Avenda wins FDA IDE nod for AI-enabled prostate cancer therapy
Avenda Health announced that it received FDA investigational device exemption (IDE) for its FocalPoint ablation system power by iQuest. The IDE will allow Avendra to combine the two technologies in a randomized, controlled trial to show superiority over the standard of care for the treatment of prostate cancer. iQuest uses artificial intelligence (AI) and deep […]
Axonics expects 40% revenue growth this year
Axonics (Nasdaq:AXNX) shares are on the rise today on second-quarter results that came in ahead of the consensus forecast amid a successful TV advertising campaign. The Irvine, California–based sacral neuromodulation technology developer posted losses of $34.1 million, or 47¢ per share, on sales of $69 million for the three months ended June 30, 2022, for […]
Medtronic, ASGE to expand colon screening program for underserved communities
Medtronic (NYSE:MDT) and the American Society for Gastrointestinal Endoscopy (ASGE) today announced a program expansion. With support from Amazon Web Services’ (AWS) Health Equity Initiative, Medtronic and ASGE are expanding the Medtronic Health Equity Assistance Program for colon cancer screening in medically underserved communities across the U.S., increasing GI Genius units (provided as part of […]
Calyxo raises $32.7M for kidney stone treatment
Kidney stone removal technology developer Calyxo announced today that it closed a $32.7 million Series C financing round. Pleasanton, California–based Calyxo develops the CVAC Aspiration system designed to use irrigation and aspiration to remove kidney stones with the goal of a surgically stone-free outcome. According to a news release, Questa Capital and CRG led the […]
SpineX enrolls first patient in spinal neuromodulation technology trial
SpineX announced today that it enrolled the first patient in its pivotal trial evaluating the Scone neuromodulation device. Los Angeles-based SpineX will evaluate the safety and effectiveness of the non-invasive spinal neuromodulation technology for the treatment of neurogenic bladder. The first patient was enrolled at the Rancho Research Institute of the Rancho Los Amigos National […]
Boston Scientific to acquire majority stake in M.I. Tech
Boston Scientific (NYSE:BSX) announced today that it agreed with Synergy Innovation to purchase its majority stake in M.I. Tech. Marlborough, Massachusetts-based Boston Scientific will acquire a stake totaling approximately 64% in the publicly traded, Korea-based manufacturer and distributor of medical devices for endoscopic and urologic procedures. According to a news release, M.I. Tech created the […]
Bright Uro launches with combined $6M from seed financing, NIH grant
Bright Uro announced its company launch with $6 million in total funding, including a grant from the National Institutes of Health (NIH). Aliso Viejo, California-based Bright Uro aims to transform care for lower urinary tract symptoms (LUTS) with innovations in urodynamics. The company pulled in $4 million in seed financing from Academy Investor Network, surgical […]
DoMore Diagnostics wins CE mark for AI algorithm that predicts colorectal cancer outcomes
DoMore Diagnostics announced that it received CE mark approval in Europe for its Histotype Px Colorectal deep learning algorithm. Oslo, Norway-based DoMore designed its Histotype Px Colorectal deep learning algorithm to predict colorectal cancer patient outcomes based on analysis of digital histology images. The company said in a news release that the algorithm, which builds […]
Teleflex’s UroLift cleared in China to treat BPH
Teleflex (NYSE:TFX) today announced it received National Medical Products Administration (NMPA) approval for its UroLift system in China to treat benign prostatic hyperplasia (BPH). Wayne, Pennsylvania-based Teleflex designed UroLift as a minimally invasive treatment option for lower urinary tract symptoms due to BPH and is indicated in the U.S. for the treatment of an enlarged prostate […]
The road to a robot: Medtronic’s development process for its Hugo RAS system
Elephants are the perfect analogy for surgical robotics, Medtronic (NYSE:MDT) VP of Marketing for Surgical Robotics Mike Stow says. Speaking on the “Road to a robot: Designing technology to address unmet needs & barriers” panel at DeviceTalks Boston last week, Stow explained that elephants are big, taking up a lot of space and that they […]